[/(
The/DT
inhibitory/JJ
effect/NN
of/IN
hydrocortisone/NN
on/IN
the/DT
chemotactic/JJ
migration/NN
of/IN
human/JJ
leukocytes/NNS
]/)

Random/JJ
migration/NN
(/(
RM/NN
)/)
and/CC
chemotactic/JJ
migration/NN
(/(
ChtM/NN
)/)
of/IN
human/JJ
leukocytes/NNS
to/TO
yeast/NN
activated/JJ
serum/NN
were/VBD
studied/VBN
with/IN
the/DT
modified/VBN
Boyden/NN
chamber/NN
method/NN
./.
=====
Both/CC
RM/NN
and/CC
ChtM/NN
showed/VBD
circadian/JJ
rhythm/NN
./.
=====
Leukocytes/NNS
migrated/VBD
most/RBS
rapidly/RB
at/IN
night/NN
./.
=====
The/DT
difference/NN
between/IN
the/DT
peak/NN
(/(
0/CD
:/:
00/CD
)/)
and/CC
trough/NN
values/NNS
(/(
8/CD
:/:
00/CD
)/)
of/IN
RM/NN
and/CC
ChtM/NN
was/VBD
significant/JJ
statistically/RB
(/(
P/NN
less/JJR
than/IN
0.01/CD
)/)
./.
=====
ChtM/NN
was/VBD
inhibited/VBN
by/IN
hydrocortisone/NN
(/(
F/NN
)/)
of/IN
physiological/JJ
concentration/NN
(/(
10/CD
(/(
-9/CD
)/)
-10/CD
(/(
-7/CD
)/)
mol/L/NN
)/)
which/WDT
was/VBD
dose-dependent/JJ
and/CC
completely/RB
antagonized/VBN
by/IN
the/DT
competitive/JJ
antagonist/NN
,/,
RU38486/NN
./.
=====
The/DT
inhibitory/JJ
effect/NN
was/VBD
much/RB
more/RBR
evident/JJ
with/IN
higher/JJR
dose/NN
(/(
more/JJR
than/IN
10/CD
(/(
-5/CD
)/)
mol/L/NN
)/)
and/CC
it/PRP
was/VBD
also/RB
reversed/VBN
by/IN
RU38486/NN
,/,
but/CC
only/RB
partially/RB
./.
=====
It/PRP
is/VBZ
suggested/VBN
that/IN
glucocorticoids/NNS
(/(
GC/NN
)/)
may/MD
be/VB
a/DT
physiological/JJ
regulator/NN
of/IN
the/DT
activity/NN
of/IN
leukocytes/NNS
and/CC
its/PRP$
inhibitory/JJ
action/NN
on/IN
ChtM/NN
may/MD
be/VB
involved/VBN
in/IN
antiinflammatory/JJ
mechanisms/NNS
of/IN
GC/NN
of/IN
pharmacological/JJ
doses/NNS
./.
=====
The/DT
action/NN
of/IN
physiological/JJ
and/CC
pharmacological/JJ
concentration/NN
of/IN
GC/NN
may/MD
be/VB
mediated/VBN
by/IN
low/JJ
affinity/NN
specific/JJ
binding/VBG
sites/NNS
of/IN
glucocorticoid/NN
receptors/NNS
./.